Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol.
BACKGROUND
Magnolol, a compound isolated from the cortex of Magnolia officinalis, has been found to possess anti-allergic and anti-asthmatic activity.


METHODS
The effect of magnolol on ionic currents was studied in cultured smooth muscle cells of human trachea with the aid of the patch clamp technique.


RESULTS
In whole cell current recordings magnolol reversibly increased the amplitude of K+ outward currents. The increase in outward current caused by magnolol was sensitive to inhibition by iberiotoxin (200 nM) or paxilline (1 microM) but not by glibenclamide (10 microM). In inside out patches, magnolol added to the bath did not modify single channel conductance but effectively enhanced the activity of large conductance Ca2+ activated K+ (BK(Ca)) channels. Magnolol increased the probability of these channel openings in a concentration dependent manner with an EC50 value of 1.5 microM. The magnolol stimulated increase in the probability of channels opening was independent of internal Ca2+. The application of magnolol also shifted the activation curve of BK(Ca) channels to less positive membrane potentials. The change in the kinetic behaviour of BK(Ca) channels caused by magnolol in these cells is the result of an increase in dissociation and gating constants.


CONCLUSIONS
These results provide evidence that, in addition to the presence of antioxidative activity, magnolol is potent in stimulating BK(Ca) channel activity in tracheal smooth muscle cells. The direct stimulation of these BK(Ca) channels by magnolol may contribute to the underlying mechanism by which it acts as an anti-asthmatic compound.
Wu
S-N
SN
Department of Medical Education and Research, Kaohsiung-Veterans General Hospital, Kaohsiung City, Taiwan. snwu@isca.vghks.gov.tw
Chen
C-C
CC
Li
H-F
HF
Lo
Y-K
YK
Chen
S-A
SA
Chiang
H-T
HT
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002478:Cells, Cultured; D005070:Evans Blue / Q000494:pharmacology; D044950:Flavanones; D005419:Flavonoids / Q000494:pharmacology; D006034:Glycyrrhetinic Acid / Q000494:pharmacology; D006801:Humans; D051036:Large-Conductance Calcium-Activated Potassium Channels; D017705:Lignans; D008564:Membrane Potentials / Q000187:drug effects; D009130:Muscle, Smooth / Q000378:metabolism*; D009544:Niflumic Acid / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D015221:Potassium Channels / Q000187:drug effects*; D024681:Potassium Channels, Calcium-Activated; D014132:Trachea / Q000378:metabolism*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001713:Biphenyl Compounds; D002121:Calcium Channel Blockers; D044950:Flavanones; D005419:Flavonoids; D051036:Large-Conductance Calcium-Activated Potassium Channels; D017705:Lignans; D015221:Potassium Channels; D024681:Potassium Channels, Calcium-Activated; C005498:magnolol; D005070:Evans Blue; C006680:baicalein; D009544:Niflumic Acid; D006034:Glycyrrhetinic Acid; D011188:Potassium; D002118:Calcium